US Skin Care Actives and Formulation Patents Granted in 2009

Thank you for visiting FormulaScan . Please click on the Patent No to study the full patent document

US PATENTS IN SKIN CARE ACTIVES GRANTED IN 2009



Patent No.: US7477938B2  Issued: 13/Jan/2009

Title: Device for delivery of active agents to barrier membranes

Applicant/Assignee: JOHNSON & JOHNSON COSUMER COMPANIES, INC

Application No.: 10/610242   Filing Date: 30/Jun/2003

Abstract:

The present invention features a device having a barrier membrane contacting surface, the device containing: a power source

a first conductive electrode

a second conductive electrode

and a carrier containing an active agent

wherein the power source is in electric communication with the first conductive electrode and the second conductive electrode, wherein the first conductive electrode and the second conductive electrode are in ionic communication with the carrier, and wherein the carrier is in communication with the barrier membrane contacting surface.

Priority:

Inventor: SUN YING [US]; LIU JUE-CHEN [US]; WU JEFFREY M [US]


Patent No.: US7477939B2  Issued: 13/Jan/2009

Title: Methods of treating a wound with galvanic generated electricity

Applicant/Assignee: JOHNSON & JOHNSON CONSUMER COMPANIES, INC

Application No.: 10/874860   Filing Date: 23/Jun/2004

Abstract:

The present invention features a method of treating a wound by applying electricity to a barrier membrane in need of such treatment wherein said electricity is generated by a first conductive electrode in electric communication with a second conductive electrode, wherein both the first conductive electrode and the second conductive electrode are in ionic communication with the barrier membrane, wherein the difference of the standard potentials of the first conductive electrode and the second conductive electrode is at least 0.2 V and wherein the electrons that pass between the first conductive electrode and the second conductive electrode are generated as a result of such difference of the standard potentials.

Priority: US2003-685282 Applic. Date: 2003-10-14; US2003-609727 Applic. Date: 2003-06-30

Inventor: SUN YING [US]; WU JEFFREY [US]; LIU JUE-CHEN [US]; OMER ALIYA [US]


Patent No.: US7477940B2  Issued: 13/Jan/2009

Title: Methods of administering an active agent to a human barrier membrane with galvanic generated electricity

Applicant/Assignee: J&J CONSUMER COMPANIES, INC

Application No.: 10/874916   Filing Date: 23/Jun/2004

Abstract:

The present invention features a method of administering an active agent to a human barrier membrane by applying to the membrane a device including a housing having the barrier membrane contacting surface, a first conductive electrode, a second conductive electrode, and a carrier containing the active agent

wherein the first conductive electrode is in electric communication with the second conductive electrode, wherein the first conductive electrode and the second conductive electrode are in ionic communication with the carrier, and wherein the carrier is in communication with the barrier membrane through the barrier membrane contacting surface, wherein the difference of the standard potentials of the first conductive electrode and the second conductive electrode is at least 0.2 V and wherein the electrons that pass between the first conductive electrode and the second conductive electrode are generated as a result of such difference of the standard potentials.

Priority: US2003-685282 Applic. Date: 2003-10-14; US2003-609727 Applic. Date: 2003-06-30

Inventor: SUN YING [US]; WU JEFFREY [US]; LIU JUE-CHEN [US]


Patent No.: US7479476B2  Issued: 20/Jan/2009

Title: Antimicrobial compositions comprising polymeric stabilizers

Applicant/Assignee: BASF AKTIENGESELLSCHAFT

Application No.: 10/581007   Filing Date: 01/Dec/2004

Abstract:

Antimicrobial composition comprising iodide and thiocyanate anions, periodic acid, and nitrogen and/or phosphorous containing polymers.

Priority: GB20030028156 Applic. Date: 2003-12-04; WO2004EP13606 Applic. Date: 2004-12-01

Inventor: ASHWORTH DAVID WILSON [GB]; HODGKINSON DARREN [GB]; HUFF JUERGEN [DE]


Patent No.: US7485110B2  Issued: 03/Feb/2009

Title: Wipe comprising a pathogen selective antimicrobial

Applicant/Assignee: KIMBERLY-CLARK WORLDWIDE, INC KIMBERLY CLARK WORLDWIDE, INC

Application No.: 10/608661   Filing Date: 27/Jun/2003

Abstract:

Wet wipes comprising a pathogen selective antimicrobial agent and an optional broad spectrum antimicrobial agent are disclosed. The pathogen selective antimicrobial agent is a Yucca species extract. The optional broad spectrum antimicrobial agent may be a synthetic broad spectrum antimicrobial agent, or a natural broad spectrum antimicrobial agent such as a botanical extract.

Priority: US2001-029404 Applic. Date: 2001-12-20

Inventor: KOENIG DAVID W [US]; KROLL LISA MARIE [US]


Patent No.: US7485183B2  Issued: 03/Feb/2009

Title: Pigment mixture, and the use thereof in cosmetics and in the foods and pharmaceuticals sector

Applicant/Assignee: MERCK PATENT GMBH

Application No.: 10/810671   Filing Date: 29/Mar/2004

Abstract:

Pigment mixtures which have at least two components, where component A comprises effect pigments based on glass flakes and component B comprises flake-form, needle-shaped, spherical or crystalline colorants or fillers, and to the use thereof, in particular in cosmetic formulations and for the coloring or as a coating of products in the foods and pharmaceuticals sector are described.

Priority: DE20031029780 Applic. Date: 2003-07-01; DE20031013981 Applic. Date: 2003-03-27

Inventor: HOCHSTEIN VERONIKA [DE]; SCHOEN SABINE [DE]


Patent No.: US7485373B2  Issued: 03/Feb/2009

Title: LOTIONED TISSUE PRODUCT WITH IMPROVED STABILITY

Applicant/Assignee: KIMBERLY-CLARK WORLDWIDE, INC

Application No.: 10/659968   Filing Date: 11/Sep/2003

Abstract:

Tissue products, such as bath tissue and facial tissue, comprising an improved lubricating formulation are disclosed. The lubricating formulation is applied to at least one surface of the tissue product and is stable at elevated temperatures, remains on or near the surface of the tissue product prior to use, and readily transfer the user=s skin upon use. The lubricating formulations described herein have a melt point viscosity of from about 5000 cPs to about 1,000,000 cPs, and a process temperature viscosity of from about 50 cPs to about 50,000 cPs. The lubricating formulations comprise an emollient, a structurant, a rheology enhancer, and other optional components.

Priority:

Inventor: KRZYSIK DUANE G [US]; BALDWIN STEPHEN [US]; NOGAJ BOZENA [US]


Patent No.: US7485750B2  Issued: 03/Feb/2009

Title: Hydroxamic Acid Derivatives and the Preparation Method Thereof

Applicant/Assignee: AMOREPACIFIC CORPORATION

Application No.: 11/919131   Filing Date: 21/Mar/2006

Abstract:

The present invention provides hydroxamic acid derivatives represented by the formula, having antioxidation, collagen biosynthesis promotion and skin pore contraction effects, and a method for preparation thereof. Further, the present invention provides skin-care external compositions for preventing skin aging, containing said hydroxamic acid derivatives represented by the formula as an active ingredient.

Priority: KR20050035986 Applic. Date: 2005-04-29; WO2006KR01019 Applic. Date: 2006-03-21

Inventor: RHO HO SIK [KR]; BAEK HEUNG SOO [KR]; LEE JEONG A [KR]; PARK CHANG MAN [KR]; KIM DUCK HOO [KR]; CHANG IH SOOP [KR]; LEE OK SUB [KR]


Patent No.: US7486989B2  Issued: 03/Feb/2009

Title: Device for delivery of oxidizing agents to barrier membranes

Applicant/Assignee: JOHNSON & JOHNSON CONSUMER COMPANIES, INC

Application No.: 10/609849   Filing Date: 30/Jun/2003

Abstract:

The present invention features a method of treating infection in a barrier membrane by applying to the membrane a device having a barrier membrane contacting surface that administers an oxidizing agent to the barrier membrane, wherein the device contains: a power source

a first conductive electrode, wherein the first conductive electrode is an inert anode

a second conductive electrode, wherein the second conductive electrode is a cathode

and a carrier containing water

wherein the power source is in electric communication with the first conductive electrode and the second conductive electrode, wherein the first conductive electrode is in ionic communication with the carrier, wherein the oxidizing agent is generated by electric current passing from the first conductive electrode through the carrier, and wherein the carrier is in communication with the barrier membrane contacting surface.

Priority:

Inventor: SUN YING [US]; LIU JUE-CHEN [US]; WU JEFFREY M [US]


Patent No.: US7488709B2  Issued: 10/Feb/2009

Title: Cleansing composition in the form of an aerosol foam without anionic surfactant, and uses in cosmetics

Applicant/Assignee: L'OREAL S.A

Application No.: 11/287298   Filing Date: 28/Nov/2005

Abstract:

The present disclosure relates to foaming cleansing compositions without anionic surfactant, comprising, in a cosmetically acceptable medium: a) greater than 2% by weight in terms of active material of a non-betaine amphoteric or zwitterionic surfactant, relative to the total weight of the composition, b) at least one non-ionic surfactant, c) at least one propellant. The present disclosure also relates to aerosol devices containing such a composition and also to the use of these compositions in cosmetics or dermatology, for instance for cleansing keratin materials such as the skin, the hair or the scalp.

Priority: FR20040052773 Applic. Date: 2004-11-26; US20040635960P Applic. Date: 2004-12-15

Inventor: RIBERY DELPHINE [FR]; PENVERNE ISABELLE [FR]


Patent No.: US7488757B2  Issued: 10/Feb/2009

Title: Invisible antimicrobial glove and hand antiseptic

Applicant/Assignee: BECTON, DICKINSON AND COMPANY

Application No.: 10/550184   Filing Date: 24/Mar/2004

Abstract:

An alcohol based hand surgical scrub, which includes cationic anti-microbial agent preservatives, cationic polymer film-forming agents and a skin emollient, and provides a long term residual, anti-microbial "invisible glove" on the skin. The composition provides an immediate reduction in bacterial microbes. The polymer system creates an invisible film on the skin following solvent evaporation. This invisible film provides a lasting anti-microbial barrier on the skin which acts to prevent microbial growth.

Priority: US20030457054P Applic. Date: 2003-03-24; WO2004US09009 Applic. Date: 2004-03-24

Inventor: HOANG MINH QUANG [US]; HUNT DONALD EDWARD [US]


Patent No.: US7489960B2  Issued: 10/Feb/2009

Title: Method of acquiring an image of a non-dermatoglyphic zone of the skin or of a zone of the hair by means of acquisition apparatus including a non-optical sensor

Applicant/Assignee: L'OREAL

Application No.: 11/115361   Filing Date: 27/Apr/2005

Abstract:

The invention relates to a method of acquiring an image of a non-dermatoglyphic zone of the skin or the hair by means of acquisition apparatus comprising a non-optical sensor.

Priority: FR20000010144 Applic. Date: 2000-08-01; US2001-909926 Applic. Date: 2001-07-20

Inventor: LEVEQUE JEAN-LUC [FR]


Patent No.: US7491768B2  Issued: 17/Feb/2009

Title: Polymer resin formulation having anti-microbial or anti-coagulability and preparation method thereof

Applicant/Assignee:

Application No.: 10/519345   Filing Date: 23/Dec/2004

Abstract:

The present invention relates to an anti-microbial or anti-coagulating polymer resin and a method for preparing the same, and a medical appliance or instrument using the same, and more particularly to a method for preparing an anti-microbial or anti-coagulating medical polymer resin comprising the steps of simply mixing a polymer resin with at least one kind of pharmaceutically active material without using a solvent. The pharmaceutically active material is preferably an anti-microbial or anti-coagulant.

According to the present invention, an anti-microbial or anti-coagulating material that is safe to a human body is mixed with a polymer resin by simple addition in an environmentally favorable non-solvent method, thereby maintaining superior anti-microbial effects even after high temperature molding, minimizing a released amount of anti-microbial to increase anti-microbial effect durability, and solving a toxic problem in a body. Therefore, the present invention can be extensively applied for medical appliances/instruments for a human body.

Priority: KR20020035793 Applic. Date: 2002-06-25; WO2003KR01249 Applic. Date: 2003-06-25

Inventor: MOON WOONG-SIG [KR]; KIM JAE-CHUL [KR]; BYOUN YOUN-SEOP [KR]; CHUNG KYOO-HYUN [KR]; KANG HEUN-SOO [KR]; KONG KI-OH [KR]; HWANG JUNG-HWA [KR]


Patent No.: US7496125B2  Issued: 24/Feb/2009

Title: Composite laser rod, fabricating method thereof, and laser device therewith

Applicant/Assignee: KONOSHIMA CHEMICAL CO. LTD

Application No.: 11/561301   Filing Date: 17/Nov/2006

Abstract:

As a composite laser rod capable of satisfying the positional stability and output stability of a laser beam, a laser rod in which a laser active element is doped is intimately inserted into a hollow portion of a non-doped ceramic pipe that has a crystal structure the same as the laser rod followed by baking so as to remove a gap and strain at an interface between the laser rod and the ceramic pipe after the baking further followed by polishing a surface of the ceramic pipe to form a ceramic skin layer, and thereby a composite laser rod is formed. In the composite laser rod, an influence due to fluctuation in the cooling capacity of cooling water or a heat sink is averaged by a non-doped skin layer, temperature fluctuation of the laser rod is suppressed, and an influence of vibration from the cooling water or a cooling fan can be suppressed.

When the refractive index of the laser rod is made higher than that of the ceramic pipe, a high efficiency oscillation can be realized, and furthermore when the thermal conductivity of the ceramic pipe is made higher than that of the laser rod, the thermal lens effect can be alleviated.

Priority: JP20020051360 Applic. Date: 2002-02-27; US2003-372836 Applic. Date: 2003-02-26

Inventor: KOUTA HIKARU [JP]; SUZUKI YOSHIKAZU [JP]; KUDO SHUETSU [JP]; TSUNEKANE MASAKI [JP]; MUKAIHARA KATSUJI [JP]; YANAGITANI TAKAGIMI [JP]; YAGI HIDEKI [JP]


Patent No.: US7498310B1  Issued: 03/Mar/2009

Title: Cosmetic or dermatological preparations comprising oligopeptides for lightening the skin of age marks and/or for preventing tanning of the skin, in particular tanning of the skin caused by UV radiation

Applicant/Assignee: BEIERSDORF AG

Application No.: 09/132799   Filing Date: 13/Aug/1998

Abstract:

Cosmetic or pharmaceutical preparations which are distinguished by an effective content of one or more monomeric or homo- or heterodimer or homo- or heterotrimeric or homo- or heterotetrameric oligopeptides, where these oligopeptides are based on a structure Val-Val-Arg-Pro SEQ ID NO:1 as homo- or heteromonomer.

Priority:

Inventor: SCHOENROCK UWE [DE]; MAX HEINER [DE]; HEARING VINCENT J [US]


Patent No.: US7502643B2  Issued: 10/Mar/2009

Title: Method and apparatus for measuring heart related parameters

Applicant/Assignee: BODYMEDIA, INC

Application No.: 10/940889   Filing Date: 13/Sep/2004

Abstract:

A monitor device and associated methodology are disclosed which provide a self contained, relatively small and continuously wearable package for the monitoring of heart related parameters, including ECG. The detection of heart related parameters is predicated on the location of inequipotential signals located within regions of the human body conventionally defined as equivalent for the purpose of detection of heart related electrical activity, such as on single limbs. Amplification, filtering and processing methods and apparatus are described in conjunction with analytical tools for beat detection and display.

Priority: US20030502764P Applic. Date: 2003-09-12; US20030510013P Applic. Date: 2003-10-09; US20040555280P Applic. Date: 2004-03-22

Inventor: FARRINGDON JONATHAN [US]; STIVORIC JOHN M [US]; TELLER ERIC [US]; ANDRE DAVID [US]; BOEHMKE SCOTT K [US]; GASBARRO JAMES [US]; KOVACS GREGORY [US]; PELLETIER RAYMOND [US]; KASABACH CHRISTOPHER [US]


Patent No.: US7504091B2  Issued: 17/Mar/2009

Title: Antiperspirant compositions

Applicant/Assignee: UNILEVER HOME & PERSONAL CARE USA DIVISION OF CONOPCO, INC UNILEVER HOME & PERSONAL CARE USA, DIVISION OF CONOPCO, INC

Application No.: 11/105131   Filing Date: 13/Apr/2005

Abstract:

antiperspirant compositions comprise an antiperspirant active and a carrier oil in which the carrier oil comprises an aromatic ester oil obeying the general formula: R1-CO2-X-Y-R2 in which R1 and R2 each represent a phenyl group, X represents an alkylene group containing from 2 to 4 carbons including at least one pendant alkyl group and Y represents a bond, or an ether or ester linkage.

Priority: GB20040008288 Applic. Date: 2004-04-14

Inventor: FRANKLIN KEVIN RONALD [GB]


Patent No.: US7507228B2  Issued: 24/Mar/2009

Title: Device containing a light emitting diode for treatment of barrier membranes

Applicant/Assignee: JOHNSON & JOHNSON CONSUMER COMPANIES, INC

Application No.: 10/609708   Filing Date: 30/Jun/2003

Abstract:

The present invention features a device having a barrier membrane contacting surface, the device containing: a power source

a first conductive electrode

a second conductive electrode

a first light emitting diode

and a carrier containing an active agent

wherein the power source is in electric communication with the first conductive electrode, the second conductive electrode, and the light emitting diode, and wherein the device is arranged such that light from the first light emitting diode and the carrier are in communication with the barrier membrane contacting surface.

Priority:

Inventor: SUN YING [US]; LIU JUE-CHEN [US]; WU JEFFREY M [US]; KOLLIAS NIKIFOROS [US]


Patent No.: US7510703B2  Issued: 31/Mar/2009

Title: UV-photoprotecting/sunscreen compositions comprising silane/siloxane derivatives of merocyanine sulfones

Applicant/Assignee: L'OREAL

Application No.: 11/725485   Filing Date: 20/Mar/2007

Abstract:

Topically applicable cosmetic compositions useful for the UV-A photoprotection of the skin and/or hair contain thus effective amounts of at least one silane, siloxane or polysiloxane merocyanine sulfone having at least one of the structural formulae (1), (2) and (3) below:

Priority: FR20040052093 Applic. Date: 2004-09-20; WO2005FR02129 Applic. Date: 2005-08-24; US20040613967P Applic. Date: 2004-09-29

Inventor: RICHARD HERVE [FR]


Patent No.: US7510734B2  Issued: 31/Mar/2009

Title: Skin treatment method with lactobacillus extract

Applicant/Assignee: E-L MANAGEMENT CORPORATION

Application No.: 11/070810   Filing Date: 02/Mar/2005

Abstract:

The present invention relates to a method of stimulating beta-defensins in skin cells which comprises applying to the skin cells an effective amount of a Lactobacillus extract or active fraction thereof.

Priority: US20040550078P Applic. Date: 2004-03-04

Inventor: SULLIVAN MICHAEL [US]; SCHNITTGER STEVEN F [US]; MAMMONE THOMAS [US]; GOYARTS EARL C [US]


Patent No.: US7511078B2  Issued: 31/Mar/2009

Title: Antiallergic agents, drugs, foods, drinks or cosmetics containing them and process for producing the same

Applicant/Assignee: KIKKOMAN CORPORATION

Application No.: 10/312504   Filing Date: 27/Dec/2002

Abstract:

The present invention provides an antiallergic agent comprising, as an active ingredient, at least one of a tomato extract, tomato pericarp, naringenin chalcone or its derivatives, tricaffeoylquinic acid or its derivatives and dicaffeoylsuccinylquinic acid or its derivatives

a histamine-release inhibitor or a leukotriene-release inhibitor

and a medicament, food, drink or cosmetic comprising the antiallergic agent, the histamine-release inhibitor or the leukotriene-release inhibitor mentioned above

and a method for producing an antiallergic agent comprising extracting raw material tomato with a solvent.

Priority: JP20000194825 Applic. Date: 2000-06-28; WO2001JP05553 Applic. Date: 2001-06-28; JP20000198733 Applic. Date: 2000-06-30; JP20000198734 Applic. Date: 2000-06-30

Inventor: YAMAMOTO TAICHI [JP]; KANAMORI TOMOKO [JP]; YAMAGUCHI FUMIO [JP]; SAITO MAKOTO [JP]; TSUJI RYOHEI [JP]; OBATA AKIO [JP]


Patent No.: US7514071B2  Issued: 07/Apr/2009

Title: Single-use cosmetic article

Applicant/Assignee: L'OREAL S.A

Application No.: 11/074056   Filing Date: 08/Mar/2005

Abstract:

The present patent application relates to a single-use cosmetic article containing a water-insoluble substrate impregnated with an aqueous cosmetic composition, said substrate being permeable and containing at least a first group of fibers and at least a second group of fibers whose hydrophilicity is different from that of the fibers of the first group. The first and second groups of fibers are arranged such that a first face of the substrate has a hydrophilicity substantially greater than the hydrophilicity of a second face of the substrate, opposite the first face.

Priority: FR20040050469 Applic. Date: 2004-03-08; US20040553129P Applic. Date: 2004-03-16

Inventor: SIMON PASCAL [FR]; CHABOUSSANT-ROCHE ANNE-CLOTILDE [FR]


Patent No.: US7518005B2  Issued: 14/Apr/2009

Title: Water-soluble anti-dandruff compounds and compositions thereof

Applicant/Assignee: GALAXY SURFACTANTS LIMITED

Application No.: 11/226791   Filing Date: 14/Sep/2005

Abstract:

Water-soluble and water dispersible undecylenic amido propyl dimethyl hydroxyl ethoxy ethyl ammonium undecylenate compounds of formula I having anti-dandruff, preservative and sunscreen activity wherein R1, R2 are from C1-C6 carbon atoms, R3 is undecylenic acid, amino group is selected from dimethyl amino propyl amine. Personal care compositions comprising compounds of formula I

Priority: IN2005MU00156 Applic. Date: 2005-02-14

Inventor: PATIL SUDHIR [IN]; MHATRE DILIP [IN]; D SOUZA AVILA [IN]


Patent No.: US7521477B2  Issued: 21/Apr/2009

Title: Vitamin c derivatives with peptide, preparation method thereof and composition comprising the same

Applicant/Assignee: PEPTRON CO., LTD

Application No.: 10/554667   Filing Date: 07/Apr/2004

Abstract:

Disclosed are vitamin C derivatives linked with a peptide or a pharmaceutically acceptable salt thereof, a method of preparing the same, and a composition comprising the same.

Priority: KR20030027735 Applic. Date: 2003-04-30; KR20040018506 Applic. Date: 2004-03-18; WO2004KR00804 Applic. Date: 2004-04-07

Inventor: CHOI HO IL [KR]; KIM SUN YOUNG [KR]; KIM HEUNG JAE [KR]; CHOI JUNG WOO [KR]


Patent No.: US7524800B2  Issued: 28/Apr/2009

Title: MONO-, DI- AND POLYOL PHOSPHATE ESTERS IN PERSONAL CARE FORMULATIONS

Applicant/Assignee: RHODIA INC

Application No.: 12/137589   Filing Date: 12/Jun/2008

Abstract:

A hydrophilized personal care formulation, which can be in the form of a hand or body soap (liquid or bar), lipstick, body wash, makeup remover, skin cleaner, hair conditioner, skin or hair moisturizer. The formulation employs an organophosphorus material or a mixture of an organophosphorus material, for example, mono-, di-, and polyol phosphate esters.

Priority: US20070943487P Applic. Date: 2007-06-12

Inventor: FUETTERER TOBIAS JOHANNES [SG]; HOUGH LAWRENCE ALAN [US]; REIERSON ROBERT LEE [US]


Patent No.: US7524808B2  Issued: 28/Apr/2009

Title: HARD SURFACE CLEANING COMPOSITION WITH HYDROPHILIZING AGENT AND METHOD FOR CLEANING HARD SURFACES

Applicant/Assignee: RHODIA INC

Application No.: 12/137738   Filing Date: 12/Jun/2008

Abstract:

A composition for cleaning or rinsing hard surfaces in an aqueous or aqueous/alcoholic medium including at least one organophosphorus material for contributing to said surfaces antideposition and/or antiadhesion properties with regard to soiling substances capable of being deposited on the surfaces.

Priority: US20070943517P Applic. Date: 2007-06-12

Inventor: FUETTERER TOBIAS JOHANNES [SG]; HOUGH LAWRENCE ALAN [US]; REIERSON ROBERT LEE [US]


Patent No.: US7527806B2  Issued: 05/May/2009

Title: Personal care article with distinct active zone

Applicant/Assignee: UNILEVER HOME & PERSONAL CARE USA DIVISION OF CONOPCO, INC

Application No.: 10/134207   Filing Date: 26/Apr/2002

Abstract:

A disposable, single-use, personal care article is disclosed having an active zone, an adjacent non-active zone, and interface therebetween

a benefit agent releasably associated with the active zone

a carrier solvent and optionally a visual indicator associated with the active zone. In one embodiment, the benefit agent, the carrier solvent, and a dye indicator are combined and applied as stripes on the article. The stripes will not substantially bleed into the adjacent non-active zone and will disappear during use of the article indicating that the benefit agent has been transferred to the skin or hair of the user.

Priority:

Inventor: GOTT ROBERT EDWARD [US]; PADLO EWA [US]; SLAVTCHEFF CRAIG STEPHEN [US]


Patent No.: US7527813B2  Issued: 05/May/2009

Title: Cosmetic composition containing an extract of Limnocitrus littoralis

Applicant/Assignee: LVMH RECHERCHE

Application No.: 11/805390   Filing Date: 23/May/2007

Abstract:

The invention relates to a cosmetic composition, characterized in that it contains, as active agent, an extract of Limnocitrus littoralis obtained by extraction with an extraction solvent selected from the group comprising alcohols and aqueous-alcoholic mixtures, in a cosmetically acceptable vehicle compatible with topical application. It further relates to a method of cosmetic treatment intended especially for soothing non-pathological skin manifestations of inflammatory origin and/or preventing and/or combating the effects of intrinsic and/or photoinduced ageing, comprising the application to the skin of a cosmetic composition of the invention.

Priority: FR20060052784 Applic. Date: 2006-07-04

Inventor: SAUVAN NANCY [FR]; RENIMEL ISABELLE [FR]; LAMY CECILE [FR]; DUPONT DELPHINE [FR]


Patent No.: US7528100B2  Issued: 05/May/2009

Title: Derivatized polysaccharide polymer

Applicant/Assignee: RHODIA INC

Application No.: 11/282501   Filing Date: 18/Nov/2005

Abstract:

Derivatized polysaccharide polymers that contain a fructan polymer substrate bearing one or more cationic substituent groups are useful in home and fabric care applications, in oilfield applications, and in emulsion polymerization applications.

Priority: US20040629402P Applic. Date: 2004-11-19

Inventor: GUNN EUEN [US]; GABBIANELLI ALVINO [US]; CROOKS REGAN [US]; SHANMUGANANDAMURTHY KRISHNAMURTHY [US]


Patent No.: US7531497B2  Issued: 12/May/2009

Title: Personal care composition containing a cleansing phase and a benefit phase

Applicant/Assignee: THE PROCTER & GAMBLE COMPANY

Application No.: 11/227379   Filing Date: 15/Sep/2005

Abstract:

Personal care compositions comprising a cleansing phase and a benefit phase. These products are intended to provide a multi-phase personal care composition that is packaged in physical contact while remaining stable and providing improved in-use and after-use hair and skin benefits.

Priority: US20040617392P Applic. Date: 2004-10-08

Inventor: MIDHA SANJEEV [US]; WELLS ROBERT LEE [US]; COMSTOCK BRYAN GABRIEL [US]; HEINRICH JAMES MERLE [US]; NIEBAUER MICHAEL FREDERICK [US]


Patent No.: US7532926B2  Issued: 12/May/2009

Title: Method and apparatus for skin absorption enhancement and transdermal drug delivery

Applicant/Assignee: MATTIOLI ENGINEERING LTD

Application No.: 10/963565   Filing Date: 14/Oct/2004

Abstract:

A removable component for a probe used to treat a patient's skin with a skin-treatment substance, include an attachment device having a plurality of holes for respectively accommodating a plurality of electrodes disposed on a head of the probe. It also includes at least one gauze pad disposed between the attachment device and the head of the probe. The attachment device is removably attached to the head of the probe.

Priority: US2004-784913 Applic. Date: 2004-02-24; US2003-448468 Applic. Date: 2003-05-30; US2003-397533 Applic. Date: 2003-03-27; US2002-201644 Applic. Date: 2002-07-24; US2002-074234 Applic. Date: 2002-02-14; US2001-942044 Applic. Date: 2001-08-30; US2001-922927 Applic. Date: 2001-08-07; US20010281808P Applic. Date: 2001-04-06

Inventor: BERNABEI GIAN FRANCO [IT]


Patent No.: US7534421B2  Issued: 19/May/2009

Title: s-Triazine compounds bearing at least one para-aminobenzalmalonic salt substituent and photoprotective cosmetic compositions comprised thereof

Applicant/Assignee: SOCIETE L'OREAL S.A L'OREAL

Application No.: 10/787940   Filing Date: 27/Feb/2004

Abstract:

Stable, topically applicable cosmetic/dermatological sunscreen compositions, well suited for the UV-photoprotection of human skin/keratinous materials, contain a thus effective amount of at least one novel s-triazine compound bearing at least one para-aminobenzalmalonic salt substituent.

Priority: FR20030002562 Applic. Date: 2003-03-03; US20030468995P Applic. Date: 2003-05-09

Inventor: RICHARD HERVE [FR]; LUPPI BERNADETTE [FR]


Patent No.: US7537752B2  Issued: 26/May/2009

Title: Use of a composition containing an effective quantity of at least one ion chelating agent for increasing the tolerance threshold of a sensitive or intolerant skin

Applicant/Assignee: L'OREAL

Application No.: 10/127569   Filing Date: 23/Apr/2002

Abstract:

Use of a cosmetic and/or dermatological and/or hygiene composition containing an effective quantity of at least one ion chelating agent for increasing the tolerance threshold of sensitive or intolerant skin.

Priority: FR20010005457 Applic. Date: 2001-04-23

Inventor: DE LACHARRIERE OLIVIER [FR]; JOURDAIN ROLAND [FR]


Patent No.: US7537775B2  Issued: 26/May/2009

Title: Low pH skin care compositions containing dehydroacetic acid

Applicant/Assignee: THE PROCTER & GAMBLE COMPANY

Application No.: 11/339282   Filing Date: 25/Jan/2006

Abstract:

Stable skin care compositions comprising dehydroacetic acid and a dermatologically acceptable carrier. The dermatologically acceptable carrier comprises at least one oil, said oil having a solubility in water of about 5% or less and a solubility parameter of from about 7 to about 15, and the dehydroacetic acid is distributed primarily into said oil. The compositions have a pH of about 4.5 and below.

Priority: US20050647197P Applic. Date: 2005-01-26

Inventor: COFFINDAFFER TIMOTHY WOODROW [US]; HA ROBERT BAO KIM [US]; O'DONOGHUE MARGARET ANN [US]; ROBINSON LARRY RICHARD [US]


Patent No.: US7544670B2  Issued: 09/Jun/2009

Title: HoxD3, HoxA3 and HoxB3 compositions and methods for improved wound healing

Applicant/Assignee: THE REGENTS OF THE UNIVERSITY OF CALIFORNIA

Application No.: 11/648208   Filing Date: 29/Dec/2006

Abstract:

The present invention provides methods and compositions useful in localized transfer of genetic material or proteins. Moreover, the present invention provides methods and compositions for improving and/or controlling wound healing by applying a wound care device comprising HoxD3 and/or HoxA3 and/or HoxB3. In addition, the present invention provides methods and compositions for improved wound healing in subjects having impaired healing capabilities, such as diabetic and aged subjects.

Priority: US2003-746592 Applic. Date: 2003-12-23; US2002-305667 Applic. Date: 2002-11-26; WO2002US19020 Applic. Date: 2002-06-14; US20010307632P Applic. Date: 2001-07-24; US20010298688P Applic. Date: 2001-06-14

Inventor: BOUDREAU NANCY [US]; YOUNG DAVID M [US]; MYERS CORNELIA [US]


Patent No.: US7544772B2  Issued: 09/Jun/2009

Title: Methods for regulating inflammatory mediators and peptides useful therein

Applicant/Assignee: NORTH CAROLINA STATE UNIVERSITY BIOMARCK PHARMACEUTICALS, LTD

Application No.: 11/367449   Filing Date: 06/Mar/2006

Abstract:

The present invention includes methods of modulating cellular secretory processes. More specifically the present invention relates to modulating or reducing the release of inflammatory mediators from inflammatory cells by inhibiting the mechanism associated with the release of inflammatory mediators from the vesicles or granules in the inflammatory cells. In this regard, the present invention discloses an intracellular signaling mechanism that illustrates several novel intracellular targets for pharmacological intervention in disorders involving secretion of inflammatory mediators from vesicles in inflammatory cells. MANS peptide and active fragments thereof are useful in such methods.

Priority: US2004-802644 Applic. Date: 2004-03-17; US2002-180753 Applic. Date: 2002-06-26; US20010300933P Applic. Date: 2001-06-26

Inventor: TAKASHI SHUJI [JP]; PARIKH INDU [US]; ADLER KENNETH B [US]; MARTIN LINDA D [US]; LI YUEHUA [US]


Patent No.: US7547434B2  Issued: 16/Jun/2009

Title: Compositions and methods for mitigating skin irritation

Applicant/Assignee: JOHNSON & JOHNSON CONSUMER COMPANIES, INC

Application No.: 11/223665   Filing Date: 09/Sep/2005

Abstract:

The invention relates to a composition and a method for mitigating redness or inflammation of mammalian skin comprising administering to mammalian skin a composition consisting of an effective amount of alkanolamine, feverfew or soy or mixtures thereof, one or more optional benefit agents and one or more cosmetically acceptable carriers. More particularly, it relates to a composition for mitigating skin irritations such as retinol/retinoid irritation and their applications to mammalian skin.

Priority:

Inventor: TIERNEY NEENA [US]; MARTIN KATHARINE [US]; MITCHELL PHYLLIS [US]; SOUTHALL MICHAEL [US]


Patent No.: US7547443B2  Issued: 16/Jun/2009

Title: Skin care topical ointment

Applicant/Assignee: KIMBERLY-CLARK WORLDWIDE, INC

Application No.: 10/659967   Filing Date: 11/Sep/2003

Abstract:

Topical ointment for preventing and treating diaper rash are disclosed. The topical ointments comprise an emollient, a structurant, a rheology enhancer, and other optional components. In one preferred embodiment, the topical ointment comprises a particulate material such as zinc oxide as an optional component.

Priority:

Inventor: KRZYSIK DUANE G [US]; BALDWIN STEPHEN [US]; NOGAJ BOZENA [US]


Patent No.: US7550218B2  Issued: 23/Jun/2009

Title: Apparatus for producing water onboard of a craft driven by a power plant

Applicant/Assignee: AIRBUS DEUTSCHLAND GMBH

Application No.: 10/417893   Filing Date: 16/Apr/2003

Abstract:

Water is generated onboard of a craft such as an aircraft or in a self-contained stationary system by partially or completely integrating a water generating unit into a power plant of the craft or system. The water generating unit includes one or more high temperature fuel cells which partially or completely replace the combustion chamber or chambers of the power plant. A reformer process is integrated into the high temperature fuel cell which is arranged between, on the one hand, a fan (30) and power plant compressor stages (31, 32) and, on the other hand, power plant turbine stages (33, 34). These power plant stages may be provided in such redundant numbers that safety and redundancy requirements are satisfied.

Priority: DE20021016710 Applic. Date: 2002-04-16; DE20011050261 Applic. Date: 2001-10-11

Inventor: HOFFJANN CLAUS [DE]; HEINRICH HANS-JUERGEN [DE]


Patent No.: US7550426B2  Issued: 23/Jun/2009

Title: Acetylated therapeutic procytotoxins

Applicant/Assignee: GREENVILLE HOSPITAL SYSTEM GHC RESEARCH DEVELOPMENT CORPORATION

Application No.: 11/131443   Filing Date: 18/May/2005

Abstract:

A class of procytotoxic agents is characterized by a capability to kill with target cell-specificity. Such an aspect can be a pore-forming protein which has at least one lysine residue, modified by a peptide linkage to an amino acid residue, via the epsilon amino group, and an acetyl group. These agents are useful in treating cancer, especially prostate cancer.

Priority:

Inventor: WAGNER THOMAS E [US]; YU XIANZHONG [US]


Patent No.: US7550430B2  Issued: 23/Jun/2009

Title: Cationic antimicrobial peptides and compositions

Applicant/Assignee: E.I. DU PONT DE NEMOURS AND COMPANY

Application No.: 10/920548   Filing Date: 18/Aug/2004

Abstract:

The invention described herein relates to compositions of novel antimicrobial peptides. The peptides of the present invention exhibit high antibacterial activity and low hemolytic activity. The invention further provides compositions comprising these antimicrobial peptides and methods of use thereof for killing, reducing the growth of, or preventing the growth of microorganisms. The invention also provides antimicrobial substrates and articles comprising the peptides of the present invention.

Priority: US20030496123P Applic. Date: 2003-08-18

Inventor: KEELER SHARON J [US]; LU HELEN S M [US]


Patent No.: US7560121B1  Issued: 14/Jul/2009

Title: Transdermal therapeutic system with a highly effective neuroleptic agent

Applicant/Assignee: LTS LOHMANN THERAPIE-SYSTEME AG

Application No.: 09/959201   Filing Date: 07/Apr/2000

Abstract:

A transdermal therapeutic system consisting of a backing layer, at least one active substance-containing matrix layer, which may at the same time possess pressure-sensitive adhesive properties, as well as a removable protective layer is characterized by a content of a neuroleptic, a content of at least one permeation enhancer as well as by a layer which is pressure-sensitive adhesive on the skin-facing side and based on polymers which are pure hydrocarbons.

Priority: DE19991018105 Applic. Date: 1999-04-22; WO2000EP03113 Applic. Date: 2000-04-07

Inventor: BRACHT STEFAN [DE]; HORSTMANN MICHAEL [DE]


Patent No.: US7560493B2  Issued: 14/Jul/2009

Title: Cosmetic and/or dermatological composition containing at least one oxidation-sensitive hydrophilic active principle and at least one N-vinylimidazole polymer or copolymer

Applicant/Assignee: L'OREAL

Application No.: 10/304860   Filing Date: 27/Nov/2002

Abstract:

The invention relates to a composition for topical use containing, in a physiologically acceptable medium having an aqueous phase, at least one oxidation-sensitive hydrophilic active principle and at least one non-crosslinked N-vinylimidazole polymer or copolymer, the active principle and the said polymer or copolymer both being in the aqueous phase.

Priority: FR20010015375 Applic. Date: 2001-11-28

Inventor: BIATRY BRUNO [FR]; LHEUREUX ERIC [FR]


Patent No.: US7566464B2  Issued: 28/Jul/2009

Title: Cosmetic composition to accelerate repair of functional wrinkles

Applicant/Assignee:

Application No.: 11/504119   Filing Date: 15/Aug/2006

Abstract:

A composition consisting of a combination of peptides that regenerate the dermal matrix and a rapid acting muscle relaxant derived from the extract of the plant, Acmella oleracea. By limiting cutaneous deformation caused by the contraction of facial muscles the extract increases the efficiency of the peptides in reducing expression lines.

Priority: US20050713454P Applic. Date: 2005-09-01

Inventor: BELFER WILLIAM A [US]


Patent No.: US7572776B2  Issued: 11/Aug/2009

Title: N-(PHOSPHONOALKYL)-AMINO ACIDS, DERIVATIVES THEREOF AND COMPOSITIONS AND METHODS OF USE

Applicant/Assignee:

Application No.: 12/194203   Filing Date: 19/Aug/2008

Abstract:

The present invention relates to an N-(phosphonoalkyl)-amino acid, a related compound or a derivative thereof, the N-(phosphonoalkyl)-amino acid, related compound or derivative thereof being in a form as a free acid, salt, partial salt, lactone, amide or ester, or in stereoisomeric or non-stereoisomeric form, other than N-(phosphonomethyl)-glycine or N,N-bis(phosphonomethyl)-glycine.

Also included is a composition including an N-(phosphonoalkyl)-amino acid, a related compound or a derivative thereof in a form as a free acid, salt, partial salt, lactone, amide or ester, or in stereoisomeric or non-stereoisomeric form, and a cosmetically or pharmaceutically acceptable vehicle for topical or systemic administration to a mammalian subject, as well as a method of administering an effective amount of such a composition for alleviating or improving a condition, disorder, symptom or syndrome associated with at least one of a nervous, vascular, musculoskeletal or cutaneous system.

Priority: US2007-621287 Applic. Date: 2007-01-09; US20060757614P Applic. Date: 2006-01-10

Inventor: YU RUEY J [US]; VAN SCOTT EUGENE J [US]


Patent No.: US7575574B2  Issued: 18/Aug/2009

Title: APPARATUS FOR PIEZOELECTRIC LAYER-WISE PUMP AND VALVE FOR USE IN LOCAL ADMINISTRATION OF BIOLOGICAL RESPONSE MODIFIERS AND THERAPEUTIC AGENTS

Applicant/Assignee: PHARMACO KINESIS CORP PHARMACO KINESIS CORPORATION

Application No.: 11/959419   Filing Date: 18/Dec/2007

Abstract:

A method and apparatus for local infusion of a variety of biological response modifiers (BRMs) and chemotherapeutic agents including tumor necrosis factors (TNF) is described. In one embodiment, the device contains a synthetic pouch compartmentalized into three or more chambers, and an electronic apparatus controlling and modulating the delivery of the agents to the site of the tumor, so as to achieve a desired regimen in support of the elimination of a tumor burden. In one embodiment, an electronic system provides tailored and controlled regulation of the administration of such agents, using sensors to monitor the progress of the treatment. Desired dosing and scheduling of anti-tumor agents in a local setting is provided.

In one embodiment, active control and regulation of the administration of medicating agents is attached to a synthetic pouch and with the aid of a piezoelectric valve and pump actuating mechanism. The apparatus provides the desired dose, duration and timing of dose delivery.

Priority: US2003-614685 Applic. Date: 2003-07-03; US20020393933P Applic. Date: 2002-07-03

Inventor: SHACHAR YEHOSHUA [US]


Patent No.: US7575926B1  Issued: 18/Aug/2009

Title: Method of identification of compounds effective against suppressed cancer cells

Applicant/Assignee: THE BOARD OF REGENTS OF THE UNIVERSITY OF OKLAHOMA

Application No.: 11/642313   Filing Date: 19/Dec/2006

Abstract:

A method for identifying compounds capable of targeting suppressed cancer cells, the method including the steps of comparing the response to a test compound of cancer cells grown on a suppressing cell support matrix which causes suppression of a malignant phenotype in a growing cancer cell and on a non-suppressing cell support matrix.

Priority: US20050751698P Applic. Date: 2005-12-19

Inventor: HURST ROBERT E [US]; IHNAT MICHAEL A [US]; KYKER KIMBERLY D [US]


Patent No.: US7579400B2  Issued: 25/Aug/2009

Title: Particles having an organized internal structure which are dispersed in an aqueous phase, the preparation thereof and use of same

Applicant/Assignee: RHODIA CHIMIE

Application No.: 10/497882   Filing Date: 23/Jun/2005

Abstract:

The invention relates to particles comprising: at least one ionically-charged water-soluble polymer

at least one surfactant having an ionic charge opposite to that of said polymer

and at least one water-soluble block copolymer having at least one non-ionic hydrophilic block and at least one non-ionic hydrophobic or ionic block. The invention also relates to a method of obtaining such particles consisting in: preparing a first aqueous mixture comprising the water-soluble, ionically-charged polymer and, if necessary, the water-soluble block copolymer if said copolymer has the same charge

subsequently, a second mixture is added to the above mixture, said second mixture comprising the surfactant and, if necessary, the water-soluble block copolymer if said copolymer has the same charge as the surfactant or if it is not ionically charged.

Furthermore, the invention relates to the use of water-soluble block copolymers as an agent for stabilizing particles with a mesophase-forming internal structure, the internal structure of the resulting particles forming the same mesophase.

Priority: US20010340381P Applic. Date: 2001-12-12; WO2002FR04275 Applic. Date: 2002-12-10

Inventor: BAVOUZET BRUNO [FR]; BEYERMANN JOCHEN [DE]; HERVE PASCAL [FR]


Patent No.: US7582306B2  Issued: 01/Sep/2009

Title: Pseudoceramides and cosmetic compositions comprising the same

Applicant/Assignee: COREANA COSMETICS CO., LTD

Application No.: 10/505758   Filing Date: 04/Nov/2004

Abstract:

The present invention relates to a pseudoceramide represented by the following formula (I) and a cosmetic composition comprising the same: wherein Z represents -OH and Y represents -OH, with the proviso that X is Z represents -OH and X represents -OH, with the proviso that Y is Y represents -OH and X represents -OH, with the proviso that Z is R represents a linear or branched, saturated or unsaturated aliphatic hydrocarbon group

and when substituted, R has one or more -OH groups.

Priority: WO2002KR00314 Applic. Date: 2002-02-26

Inventor: LEE JUNG-NO [KR]; LEE KANG-TAE [KR]; JEONG JEE-HEAN [KR]; JO BYONG-KEE [KR]


Patent No.: US7582677B2  Issued: 01/Sep/2009

Title: Lignan formulations

Applicant/Assignee: HORMOS MEDICAL CORP

Application No.: 10/513218   Filing Date: 03/Nov/2004

Abstract:

A topical formulation which includes a lignan or lignan ester in a dermatologically acceptable vehicle. The formulation can be either a cosmetic formulation or a pharmaceutical formulation.

Priority: FI20020001184 Applic. Date: 2002-06-19; WO2003FI00375 Applic. Date: 2003-05-15

Inventor: KORTE HELENA [FI]; LEHTOLA VELI-MATTI [FI]; UNKILA MIKKO [FI]; HIILOVAARA-TEIJO MERVI [FI]; AHOTUPA MARKKU [FI]


Patent No.: US7588564B2  Issued: 15/Sep/2009

Title: Apparatus for piezoelectric layer-wise pump and valve for use in local administration of biological response modifiers and therapeutic agents

Applicant/Assignee: PHARMACO KINESIS CORPORATION

Application No.: 10/614685   Filing Date: 03/Jul/2003

Abstract:

A method and apparatus for local infusion of a variety of biological response modifiers (BRMs) and chemotherapeutic agents including tumor necrosis factors (TNF) is described. In one embodiment, the device contains a synthetic pouch compartmentalized into three or more chambers, and an electronic apparatus controlling and modulating the delivery of the agents to the site of the tumor, so as to achieve a desired regimen in support of the elimination of a tumor burden. In one embodiment, an electronic system provides tailored and controlled regulation of the administration of such agents, using sensors to monitor the progress of the treatment. Desired dosing and scheduling of anti-tumor agents in a local setting is provided.

In one embodiment, active control and regulation of the administration of medicating agents is attached to a synthetic pouch and with the aid of a piezoelectric valve and pump actuating mechanism. The apparatus provides the desired dose, duration and timing of dose delivery. In one embodiment, reporting the events in the tumor site via an RF link to the external control box is provided.

Priority: US20020393933P Applic. Date: 2002-07-03

Inventor: SHACHAR YEHOSHUA [US]


Patent No.: US7588775B2  Issued: 15/Sep/2009

Title: Silicone elastomer exfoliating compositions

Applicant/Assignee: E-L MANAGEMENT CORP

Application No.: 11/112400   Filing Date: 23/Apr/2005

Abstract:

Compositions of the present invention comprise from about 40-99% of an aqueous suspension of silicone elastomer powder in a cosmetically acceptable vehicle. The compositions are useful as skin exfoliants when mechanical agitation is supplied, for example by rubbing with a hand. After exfoliation, little or no film or residue remains on the skin and washing the treated area is optional. The cosmetically acceptable vehicle may comprise a wide range of beneficial ingredients, cosmetic or dermatological actives and additives. The present invention also encompasses a method of exfoliating skin in need of such treatment.

Priority:

Inventor: MOHAMMADI FATEMEH [US]; TALATI AKSHAY [US]; CZARNOTA ANNA [US]


Patent No.: US7588783B2  Issued: 15/Sep/2009

Title: Flavonoid derivative

Applicant/Assignee: MERCK PATENT GMBH

Application No.: 10/581494   Filing Date: 05/Nov/2004

Abstract:

The invention relates to a novel flavonoid derivative, to an extract comprising the flavonoid derivative, to the cosmetic and pharmaceutical use thereof, to preparations comprising the flavonoid derivative or extract, and to a process for the preparation of the flavonoid derivative or extract.

Priority: DE20031057004 Applic. Date: 2003-12-05; WO2004EP12538 Applic. Date: 2004-11-05

Inventor: BUCHHOLZ HERWIG [DE]; WIRTH CORINNA [DE]; CAROLA CHRISTOPHE [DE]; ALVES FONTES ROSANE [BR]


Patent No.: US7588787B2  Issued: 15/Sep/2009

Title: Medicated Production For Local Use Based On Natural Materials

Applicant/Assignee:

Application No.: 11/908700   Filing Date: 25/May/2006

Abstract:

The subject of the invention is a medicated product for local use based on natural materials which said product is suitable for alleviating respectively eliminating pain of different locomotor complaints of the body applying the product through the skin surface. The product according to the invention contains menthol in water solution, ethylene-diamine-tetra-acetic acid-alkali metal, salt (EDTA), furthermore in given case it contains carrier, diluter and/or other auxiliary substances applied in producing products for local use, characterized by that, the product contains essential oils furthermore non-ionic surface-active emulsifying agent and substances in the composition of the product as follows:

Aethereum gerani 0.1 . . . 3 mass %, preferably 1.5 mass %, Aethereum rosmarini 0.1 . . . 2 mass %, preferably 0.5 mass %, Aethereum citri 0.5 . . . 3 mass %, preferably 1 mass %, Mentholum 0.1 . . . 3 mass %, preferably 1 mass %, EDTA 2Na 1 . . . 6 mass %, preferably 3 mass %.

Priority: HU20050000530 Applic. Date: 2005-05-25; WO2006HU00048 Applic. Date: 2006-05-25

Inventor: HUT DOT OVER A S ISTVAN [HU]


Patent No.: US7589051B2  Issued: 15/Sep/2009

Title: Cationic, oxidized polysaccharides in conditioning applications

Applicant/Assignee: HERCULES INCORPORATED

Application No.: 10/821013   Filing Date: 08/Apr/2004

Abstract:

A cationic, oxidized polysaccharide or derivative thereof that has a mean average molecular weight (Mw) having a lower limit of 50,000 and an upper limit of 1,000,000 and an aldehyde functionality content of at least 0.001 meq/gram is used in personal care and household care compositions. This cationic, oxidized polysaccharide is prepared in continuous or batch processes using hydrolytic reagents, oxidizing reagents, or combination of hydrolytic reagents and oxidizing reagents. Personal care or household care compositions are prepared by adding the cationic, oxidized polysaccharide to a personal care or household composition containing at least one active ingredient other than the cationic, oxidized polysaccharide of this invention.

Priority:

Inventor: ERAZO-MAJEWICZ PAQUITA [US]; MODI JASHAWANT J [US]; XU ZU-FENG [US]


Patent No.: US7591949B2  Issued: 22/Sep/2009

Title: Method for the improvement of transport across adaptable semi-permeable barriers

Applicant/Assignee: IDEA AG

Application No.: 10/984450   Filing Date: 08/Nov/2004

Abstract:

The invention relates to a method, a kit and a device for controlling the flux of penetrants across an adaptable semi-permeable porous barrier, the method comprising the steps of: preparing a formulation by suspending or dispersing said penetrants in a polar liquid in the form of fluid droplets surrounded by a membrane-like coating of one or several layers, said coating comprising at least two kinds of forms of amphiphilic substances with a tendency to aggregate, said penetrants being able to transport agents through the pores of said barrier or to enable agent permeation through the pores of said barrier after penetrants have entered the pores, selecting a dose amount of said penetrants to be applied on a predetermined area of said barrier to control the flux of said penetrants across said barrier,

and applying the selected dose amount of said formulation containing said penetrants onto said area of said porous barrier.

Priority: WO1999EP04659 Applic. Date: 1999-07-05; WO2000EP06367 Applic. Date: 2000-07-05; US2002-037480 Applic. Date: 2002-01-04

Inventor: CEVC GREGOR [DE]; RICHARDSEN HOLGER [DE]; WEILAND-WAIBEL ANDREA [DE]


Patent No.: US7592024B1  Issued: 22/Sep/2009

Title: Topical compositions containing melicope hayselii and a method of treating skin

Applicant/Assignee: AVON PRODUCTS, INC

Application No.: 12/344787   Filing Date: 29/Dec/2008

Abstract:

Cosmetic compositions comprising an extract of Melicope hayesii and methods of using such compositions to impart anti-aging benefits to the skin are disclosed. These compositions are believed to have modulatory activity against at least one biochemical pathway implicated in skin aging.

Priority:

Inventor: PTCHELINTSEV DMITRI S [US]; DRYER LAURENCE [US]


Patent No.: US7595021B2  Issued: 29/Sep/2009

Title: Method of providing alcohol-free disinfection

Applicant/Assignee: SAGE PRODUCTS, INC

Application No.: 11/507288   Filing Date: 21/Aug/2006

Abstract:

A disinfectant delivery system and method of providing alcohol-free disinfection to a body to be disinfected, as well as a method of infection reduction by preparation of a patient before an invasive procedure. A blended cloth comprising first fibers and second fibers is provided with the first fibers generally being greater in quantity by weight than the second fibers. A disinfectant solution impregnates the blended cloth, with the disinfectant solution having chlorhexidine gluconate as an active ingredient and having no alcohol. In the method according to the invention, at least one impregnated blended cloth is used to disinfect at least a portion of a body. A plurality of blended cloths can be provided for disinfecting discrete portions of the body.

When an invasive procedure is to be performed on a patient, a further method according to the invention of infection reduction comprises using a CHG-impregnated cloth to disinfect at least a portion of the patient at least one day prior to the invasive procedure proximate the location of the invasive procedure.

Priority: US2003-435898 Applic. Date: 2003-05-12

Inventor: KEATY JR THOMAS [US]; CHAKROBORTY RAM [US]; ALLEN JENNIFER M [US]; CHAWLA AJAY [US]; PANEK JR ROBERT J [US]; HANIFL PAUL H [US]


Patent No.: US7596407B2  Issued: 29/Sep/2009

Title: Transdermal iontophoretic delivery of piperazinyl-2(3H)-benzoxazolone compounds

Applicant/Assignee: SOLVAY PHARMACEUTICALS, B.V

Application No.: 11/088880   Filing Date: 25/Mar/2005

Abstract:

The invention is related to an iontophoretic method for the delivery of a compound of the formula wherein R is defined herein, and pharmaceutically acceptable salts and prodrugs thereof

and, wherein the method comprises: (a) applying a transdermal device to the skin of a living body, wherein the transdermal device has a reservoir containing the compound of formula I or a composition thereof and optionally a pharmaceutically acceptable electrolyte

(b) causing current to flow through the skin so as to iontophoretically deliver the compound of formula I. The invention is further related to iontophoretic systems and to kits containing the iontophoretic system combined with one or more cartridges containing a compound of formula I, and to cartridges containing a compound of formula I.

Priority: US20040556375P Applic. Date: 2004-03-26

Inventor: BOUWSTRA JOHANNA A [NL]; VAN DEN BERG DIRK-JAN [NL]; VERBAAN FREDERIK J [NL]; CONJEEVARAM RAJKUMAR V [US]; BANGA AJAY K [US]; VEMULAPALLI VISWATEJ [US]; TEUNISSEN HENDRIK [NL]; VAN SCHARRENBURG GUSTAAF J M [NL]


Patent No.: US7598287B2  Issued: 06/Oct/2009

Title: Use of inhibitors of indoleamine-2,3-dioxygenase in combination with other therapeutic modalities

Applicant/Assignee: MEDICAL COLLEGE OF GEORGIA RESEARCH INSTITUTE, INC

Application No.: 10/780797   Filing Date: 17/Feb/2004

Abstract:

The present invention provides improved treatment methods by the administration of both an inhibitor of indoleamine-2,3-dioxygenase in addition to the administration of an additional therapeutic agent.

Priority: US20040538647P Applic. Date: 2004-01-22; US20030459489P Applic. Date: 2003-04-01

Inventor: MUNN DAVID [US]; MELLOR ANDREW [US]


Patent No.: US7601360B2  Issued: 13/Oct/2009

Title: Excitatory amino acid inhibitors for treating sensitive skins

Applicant/Assignee: SOCIETE L'OREAL S.A L'OREAL

Application No.: 10/401685   Filing Date: 31/Mar/2003

Abstract:

Sensitive human skin/scalp/mucous membrane conditions, for example skin irritation and/or dry patches and/or erythemas and/or dysaesthesic sensations and/or sensations of heating and/or pruritus, are therapeutically treated by topically applying thereto an effective condition-alleviating amount of at least one inhibitor of at least one excitatory amino acid.

Priority: FR19970011959 Applic. Date: 1997-09-25; US1998-160151 Applic. Date: 1998-09-25

Inventor: BRETON LIONEL [FR]; NONOTTE ISABELLE [FR]


Patent No.: US7601371B2  Issued: 13/Oct/2009

Title: PENETRATING CARRIER, ANTI-FUNGAL COMPOSITION USING THE SAME AND METHOD FOR TREATMENT OF DERMATOPHYTES

Applicant/Assignee:

Application No.: 11/684869   Filing Date: 12/Mar/2007

Abstract:

A liquid carrier for topical administration is provided that contains a mineral oil, turpentine and, optionally, camphor, and optionally other terpenoid components containing pinene, and its use to provide an antifungal composition containing a mixture of antifungal essential oils and the carrier system, wherein the mixture of antifungal essential oils includes an effective amount of each of Eucalyptus globulus, peppermint, cedarwood, and Manuka

along with the use of this composition in the topical treatment of fungal infection, particularly of the nail.

Priority: US2004-956073 Applic. Date: 2004-10-04

Inventor: SELNER MARC [US]


Patent No.: US7601882B2  Issued: 13/Oct/2009

Title: Carrier for additive in an absorbent article

Applicant/Assignee: SCA HYGIENE PRODUCTS AB

Application No.: 10/800176   Filing Date: 12/Mar/2004

Abstract:

The invention relates to an absorbent article, such as a sanitary towel, a panty liner, a tampon, a diaper or an incontinence pad, which article is intended to be positioned in the crotch area of a wearer and has a surface intended during use to be in contact with skin and/or mucous membranes. The article comprises at least one absorbent body (205) and a carrier (102) containing at least one additive intended to be released from the carrier (102). The carrier (102) comprises a polysiloxane gel.

Priority: US20030454342P Applic. Date: 2003-03-14

Inventor: FARBROT ANNE [SE]; GUSTAFSSON INGRID [SE]


Patent No.: US7604812B2  Issued: 20/Oct/2009

Title: Hypoallergenic and non-irritant skin care formulations

Applicant/Assignee: ND

Application No.: 10/450666   Filing Date: 28/Nov/2003

Abstract:The invention provides novel hypoallergenic and non-irritant medical skin care formulations being water-in-oil emulsions. The formulations are free from ingredients with a known allergenic potential, such as fragrances, preservatives, colorings, plant extracts, PEGs, cetylstearyl alcohol, lanolin alcohol, lower alcohols and proteins, thus being particularly suitable for patients with sensitive dry skin. The skin care formulations of the invention are useful in the prophylaxis and treatment of dry, sensitive skin or in the therapy or therapy support of eczematous or psoriatic skin and exhibit favorable sensorial properties. The invention furthermore provides a method of manufacturing the novel hypoallergenic and non-irritant skin care formulations.

Priority: ND

Inventor: FRANKE PATRICK (DE)


Patent No.: US7604819B2  Issued: 20/Oct/2009

Title: Clay-based hemostatic agents and devices for the delivery thereof

Applicant/Assignee: Z-MEDICA CORPORATION

Application No.: 11/715057   Filing Date: 06/Mar/2007

Abstract:

A hemostatic device for promoting the clotting of blood includes a gauze substrate, a clay material disposed on the gauze substrate, and also a polyol such as glycerol or the like disposed on the gauze substrate to bind the clay material. When the device is used to treat a bleeding wound, at least a portion of the clay material comes into contact with blood emanating from the wound to cause the clotting. A bandage that can be applied to a bleeding wound to promote the clotting of blood includes a flexible substrate and a gauze substrate mounted thereon. The gauze substrate includes a clay material and a polyol. A hemostatic sponge also includes a gauze substrate and a dispersion of hemostatic material and a polyol on a first surface of the substrate.

Priority: US2006-590427 Applic. Date: 2006-10-30; US20060808618P Applic. Date: 2006-05-26; US20060810447P Applic. Date: 2006-06-01

Inventor: HUEY RAYMOND J [US]; LO DENNY [US]; BURNS DANIEL J [US]; BASADONNA GIACOMO; HURSEY FRANCIS X


Patent No.: US7605298B2  Issued: 20/Oct/2009

Title: Wound Covering

Applicant/Assignee: BIO-GATE AG

Application No.: 10/585606   Filing Date: 05/Jan/2005

Abstract:

The invention relates to a dressing for a wound, containing a first layer which is formed by an absorbent matrix and an antimicrobially active substance. The substance is provided on a surface of the matrix in a chemically or physically bonded matter. The surface of the matrix with the substance is coated with a hydrophilic polymer.

Priority: DE200410001594 Applic. Date: 2004-01-09; WO2005EP00048 Applic. Date: 2005-01-05

Inventor: BECHERT THORSTEN [DE]; STEINRUCKE PETER [DE]


Patent No.: US7608270B2  Issued: 27/Oct/2009

Title: Dosage form

Applicant/Assignee: UNIVERSITY OF HULL

Application No.: 10/877042   Filing Date: 25/Jun/2004

Abstract:

A pharmaceutical or dietetic dosage form comprising of effective quantity of an active substance chemically or physically bound to a support comprising sporopollenin, or other similar exine coating of spores, of a plant or fungus, optionally with further excipients.

Priority: US20030482922P Applic. Date: 2003-06-27

Inventor: BECKETT STEPHEN THOMAS [GB]; ATKIN STEPHEN LAWRENCE [GB]; MACKENZIE GRAHAME [GB]


Patent No.: US7611725B2  Issued: 03/Nov/2009

Title: Additives and products including oligoesters

Applicant/Assignee: CRODA, INC

Application No.: 10/356208   Filing Date: 31/Jan/2003

Abstract:

The present invention relates to oligoesters and their use or the creation of additives. Oligoester containing additives and/or oligoesters themselves may be used for formulating pharmaceutical preparations, cosmetics or personal care products such as shampoos and conditioners. These oligoesters are particularly useful for the creation of multi-purpose additives that can impart conditioning, long substantivity and/or UV protection. Individual oligoesters and oligoester mixtures are described.

Priority: US20020353669P Applic. Date: 2002-01-31; US20020353477P Applic. Date: 2002-01-31; US20020353540P Applic. Date: 2002-02-01

Inventor: PEREIRA ABEL G [US]; BARINOVA HELENA S [US]; WESTERGOM CHRISTOPHER [US]


Patent No.: US7612160B2  Issued: 03/Nov/2009

Title: Polyether urethane containing allyl groups

Applicant/Assignee: BASF AKTIENGESELLSCHAFT BASF SE

Application No.: 10/538760   Filing Date: 10/Jun/2005

Abstract:

The present invention relates to a mono- and/or polyallyl-polyether-urethane, to water-soluble or water-dispersible polymers which comprise such a polyether-urethane in copolymerized form, and to cosmetic or pharmaceutical compositions which comprise a water-soluble or water-dispersible polymer based on a mono- and/or polyallyl-polyether-urethane.

Priority: DE20021059036 Applic. Date: 2002-12-17; WO2003EP14357 Applic. Date: 2003-12-16

Inventor: NGUYEN-KIM SON [DE]; MATHAUER KLEMENS [DE]; WOOD CLAUDIA [DE]


Patent No.: US7615546B2  Issued: 10/Nov/2009

Title: Topical Delivery System for Phytosterols

Applicant/Assignee: BIODERM RESEARCH

Application No.: 12/210266   Filing Date: 15/Sep/2008

Abstract:

This invention relates to certain sugar esters of phytosterols of formula (I). These esters are useful for topical application, and for the treatment of skin condition, including age spots, acne, loss of cellular antioxidants, collagen loss, loss of skin pliability, loss of skin suppleness, skin wrinkles including fine lines, oxidation, damage from radiation, malfunction of matrix metalloproteases, malfunction of tyrosinases, damage from free radicals, damage from UV, dry skin, xerosis, ichthyosis, dandruff, brownish spots, keratoses, melasma, lentigines, liver spots, pigmented spots, dark circles under the eyes, skin pigmentation including darkened skin, blemishes, oily skin, warts, eczema, pruritic skin, psoriasis, inflammatory dermatoses, topical inflammation, disturbed keratinization, skin changes associated with aging, nail or skin requiring cleansers, conditioning or treatment, and hair or scalp requiring shampooing or conditioning, and combinations thereof

Wherein, n=0, 1, 2, or 3

and R=H, -CH2OH, -CH(OH)-CH2OH, -CH(OH)-CH(OH)-CH2OH

and R1=Substituent selected from a sapogenin, steroid, or terpenoid.

Priority: US2005-161856 Applic. Date: 2005-08-19; US2008-139659 Applic. Date: 2008-06-16

Inventor: GUPTA SHYAM K [US]


Patent No.: US7622117B2  Issued: 24/Nov/2009

Title: 3-deoxyglucosone and skin

Applicant/Assignee: DYNAMIS THERAPEUTICS, INC

Application No.: 10/198706   Filing Date: 18/Jul/2002

Abstract:

The invention relates to a method of removing 3-deoxyglucosone and other alpha-dicarbonyl sugars from skin. The invention further relates to methods of inhibiting production and function of 3-deoxyglucosone and other alpha-dicarbonyl sugars in skin. The invention also relates to methods of treating 3-deoxyglucosone and other alpha-dicarbonyl sugars associated diseases and disorders of skin.

Priority: US20020392530P Applic. Date: 2002-06-27; US20020373103P Applic. Date: 2002-04-17

Inventor: TOBIA ANNETTE [US]; KAPPLER FRANCIS [US]


Patent No.: US7622132B2  Issued: 24/Nov/2009

Title: ENCAPSULATED COSMETIC COMPOSITION

Applicant/Assignee: ELC MANAGEMENT, LLC

Application No.: 11/425446   Filing Date: 21/Jun/2006

Abstract:

The present invention relates to encapsulated cosmetic compositions that are topically applied. The compositions contain at least one frangible capsule that has a seamless shell of a thermo-softening material. The shell is solid at about room temperature and melts upon application to the skin. The shell holds a core cosmetic that is added to a clear gel base. Thus, the color of the capsule is visible and multiple colored capsules can be added to the base for a custom colored composition.

Priority: US20050694312P Applic. Date: 2005-06-27

Inventor: LEE WILSON AN-TUEN [US]; SILVEIRA LEIGH ANDERSEN [US]


Patent No.: US7625883B1  Issued: 01/Dec/2009

Title: Glycerophosphoinositol derivatives as modulators of cytosolic A2 phospholipase

Applicant/Assignee: I.R.B. ISTITUTO DI RICERCHE BIOTECHNOLOGICHE S.R.L

Application No.: 10/415881   Filing Date: 07/Nov/2000

Abstract:

Optionally O-substituted glycero-phosphoinositol derivatives, their analogues and their salts wherein the substitutents: R'1, R'2, R2, R3, R4, R5, R6 have the described meaning, their synthesis and their pharmacological effect as modulators of the activation or over-stimulation of cPLA2.

Priority: WO2000IT00447 Applic. Date: 2000-11-07

Inventor: CORDA DANIELA [IT]; DAL TOSO ROBERTO [IT]; BONVENTO GIOVANNA [IT]; MARCOLONGO GABRIELE [IT]; DAL MONTE RENZO [IT]


Patent No.: US7628999B2  Issued: 08/Dec/2009

Title: Personal care compositions

Applicant/Assignee:

Application No.: 11/801872   Filing Date: 11/May/2007

Abstract:

This invention relates to personal care compositions containing polytrimethylene ether glycol in a variety of physical forms including solutions, gels, oil-in-water emulsions, water-in-oil emulsions, suspensions and solids. In a particularly preferred embodiment, the polytrimethylene ether glycol is derived predominantly from monomers obtained from renewable resources, making the personal care products of this embodiment of the present invention more environmentally friendly in terms of their manufacture, use and disposal.

Priority: US20060801166P Applic. Date: 2006-05-17

Inventor: SUNKARA HARI BABU [US]


Patent No.: US7629371B2  Issued: 08/Dec/2009

Title: Cosmetic use of a composition containing at least one oxazoline, serving as an active substance, as a slimming product and/or for preventing and/or treating cellulite

Applicant/Assignee: LABORATOIRES EXPANSCIENCE

Application No.: 10/561173   Filing Date: 16/Dec/2005

Abstract:

The invention relates to the cosmetic use of a composition containing at least one oxazoline, serving as an active substance, as a slimming product, and to an associated cosmetic treatment method. The invention also relates to the cosmetic use of a composition containing at least one oxazoline, serving as an active substance, for preventing and/or treating cellulite.

Priority: FR20030007333 Applic. Date: 2003-06-18; WO2004FR01504 Applic. Date: 2004-06-17

Inventor: MSIKA PHILIPPE [FR]; PICCIRILLI ANTOINE [FR]; PICCARDI NATHALIE [FR]


Patent No.: US7631766B2  Issued: 15/Dec/2009

Title: COSMETIC MASK PACKAGE

Applicant/Assignee:

Application No.: 12/107942   Filing Date: 23/Apr/2008

Abstract:

A cosmetic mask package has an outer pouch, a liquid storing device and a carrier. The outer pouch has an interior surface defining an inner space. The liquid storing device is mounted in the inner space inside the outer pouch and has an inner pouch filled with liquid and a pointed instrument selectively piercing the inner pouch to release the liquid. The carrier is dry to prevent microorganism growth and is mounted in the inner space inside the outer pouch and outside the inner pouch. When the inner pouch is pierced, the carrier is moistened for use. Additional preservatives are not required so the masks are hypoallergenic and hygienic.

Priority: TW20080200405U Applic. Date: 2008-01-08

Inventor: WANG CHU-HUI [TW]


Patent No.: US7632068B2  Issued: 15/Dec/2009

Title: Control of power, loads and/or stability of a horizontal axis wind turbine by use of variable blade geometry control

Applicant/Assignee: FORSKNINGSCENTER RISO TECHNICAL UNIVERSITY OF DENMARK

Application No.: 10/551406   Filing Date: 31/Mar/2004

Abstract:

The present invention relates to a design concept by which the power, loads and/or stability of a wind turbine may be controlled by typically fast variation of the geometry of the blades using active geometry control (e.g. smart materials or by embedded mechanical actuators), or using passive geometry control (e.g. changes arising from loading and/or deformation of the blade) or by a combination of the two methods. The invention relates in particular to a wind turbine blade, a wind turbine and a method of controlling a wind turbine.

Priority: DK20030000491 Applic. Date: 2003-03-31; WO2004DK00225 Applic. Date: 2004-03-31

Inventor: BAK DAN CHRISTIAN [DK]; BUHL THOMAS [DK]; FUGLSANG PETER [DK]; MADSEN HELGE AAGAARD [DK]; RASMUSSEN FLEMMING [DK]


Patent No.: US7632919B2  Issued: 15/Dec/2009

Title: Polystyrene binding peptides and methods of use

Applicant/Assignee: E.I. DU PONT DE NEMOURS AND COMPANY

Application No.: 11/607673   Filing Date: 01/Dec/2006

Abstract:

Combinatorially generated peptides are provided that have binding affinity for polystyrene (PS). The peptides may be used to deliver benefit agents to various PS surfaces.

Priority: US20050750850P Applic. Date: 2005-12-15

Inventor: CUNNINGHAM SCOTT D [US]; LOWE DAVID J [US]; O'BRIEN JOHN P [US]; WANG HONG [US]; WILKINS ANTOINETTE E [US]


Patent No.: US7635488B2  Issued: 22/Dec/2009

Title: Patches and uses thereof

Applicant/Assignee: DBV TECHNOLOGIES

Application No.: 11/411531   Filing Date: 26/Apr/2006

Abstract:

A patch comprising a support having electrostatic properties is provided wherein a periphery of the support is coated with an adhesive material, and all or part of the non-adhesive surface of the support is covered with at least one biologically active substance in the form of particles that is adhered to the non-adhesive part of the support by electrostatic forces.

Priority: FR20010003382 Applic. Date: 2001-03-13; US2003-659566 Applic. Date: 2003-09-10; WO2002FR00804 Applic. Date: 2002-03-06

Inventor: DUPONT CHRISTOPHE [FR]; DUPONT BERTRAND [FR]; VANNEROM PIERRE-YVES [FR]; BENHAMOU PIERRE-HENRI [FR]; RONCO JORGE [FR]


Patent No.: US7635719B2  Issued: 22/Dec/2009

Title: Use of adamatyl methoxydiphenyl propenoic acid for the treatment of acne

Applicant/Assignee: SIGMA-TAU INDUSTRIE FARMACEUTICHE RIUNITE S.P.A

Application No.: 11/911749   Filing Date: 05/May/2006

Abstract:

The use of a substance belonging to the class of atypical retinoids for the topical treatment of acne is described. In particular the effects on an animal model for this skin disease of a pharmaceutical or cosmetic compound for topical use containing adamantyl methoxydiphenyl propenoic acid formulated in a gel are demonstrated.

Priority: IT2005RM00248 Applic. Date: 2005-05-20; WO2006EP62088 Applic. Date: 2006-05-05

Inventor: PISANO CLAUDIO [IT]; VESCI LOREDANA [IT]


Patent No.: US7638476B2  Issued: 29/Dec/2009

Title: WASHING AND CLEANING AGENTS COMPRISING READILY SOLUBLE CAPSULES

Applicant/Assignee: HENKEL KOMMANDITGESELLSCHAFT AUF AKTIEN (HENKEL KG AA) HENKEL AG & CO. KGAA

Application No.: 12/028389   Filing Date: 08/Feb/2008

Abstract:

Aqueous washing and cleaning agents that contain capsules in addition to other constituents, the capsules each encompassing an active ingredient in a matrix. The introduction of a combination of aluminum silicate and silicic acid into the matrix improves the solubility characteristics of the capsules in a washing operation.

Priority: DE200510038070 Applic. Date: 2005-08-10; WO2006EP07149 Applic. Date: 2006-07-20

Inventor: ORLICH BERNHARD [DE]; RICHTER BERND [DE]; HOELSKEN SOEREN [DE]; VAN DER BURGH STEFAN [DE]


Patent No.: US7638504B2  Issued: 29/Dec/2009

Title: Hepatitis a viricide

Applicant/Assignee: ECOLAB INC

Application No.: 10/168442   Filing Date: 18/Sep/2002

Abstract:

The invention relates to agents which combat the hepatitis A virus, containing only minimal amounts of chlorine-containing and/or chlorine cleaving active ingredients, or none of said substances. The inventions also relates to the use of these agents and to a method for their production.

Priority: DE19991062353 Applic. Date: 1999-12-23; WO2000EP12688 Applic. Date: 2000-12-14

Inventor: VON RHEINBABEN FRIEDRICH [DE]; BIERING HOLGER [DE]; BANSEMIR KLAUS-PETER [DE]; GLAESER SABINE [DE]

US Patents Granted in 2010
 
US Patents Granted in 2008
...or use our Search Engine to
search for patent documents by
number.
Search for anything. Simply
type the words in the box..
Clck to enlarge and view details
US PATENTS IN ACTIVES FOR SKIN CARE GRANTED IN  2009
This list includes patents granted in the United States. The list was retrieved by searching the claims section of all patent applications published. Salient search terms include skin care
active ingredients having properties such as anti-ageing, anti-wrinkle, antioxidant, acne control benefits, skin whitening or lightening, blemish removal, etc. This category includes technology
related to the synthesis and delivery of actives such as peptides, exfoliants, α-hydroxy acids, herbals, free radical scavengers, "green" derived molecules and compounds having unique
sensory properties.